期刊文献+

小分子酪氨酸激酶抑制剂AG-490对人慢性髓系白血病急变细胞株K562细胞增殖凋亡的影响 被引量:1

Effects of Small Molecule Tyrosine Kinase Inhibitors AG-490 on Proliferation and Apoptosis of Chronic Myeloid Leukemia Cell Line K562 Cells
原文传递
导出
摘要 目的探讨酪氨酸激酶抑制剂AG-490对人慢性髓系白血病急变细胞株K562细胞的增殖及凋亡的影响。方法采用MTT法观察AG-490在体外对人慢性髓系白血病急变细胞株K562细胞增殖的影响,光学显微镜下观察AG-490对K562细胞形态的变化,流式细胞术检测AG-490对K562细胞凋亡及细胞周期的影响,逆转录-聚合酶链反应(RT-PCR)及实时荧光定量PCR技术检测AG-490作用后K562细胞bcr/abl融合基因及凋亡相关基因c-myc mRNA的表达水平。结果 AG-490可明显抑制K562细胞的增殖,并随药物作用时间的延长和浓度的增加,抑制作用越明显(P<0.05);AG-490可使细胞周期阻滞于G1期,促使其凋亡(P<0.05)。AG-490作用于K562细胞48 h后bcr/abl融合基因的表达无明显改变(P>0.05),而c-myc的表达水平明显降低(P<0.05)。结论 AG-490可能通过阻断JAK2信号通路而下调c-myc的表达,使K562细胞阻滞于G1期,从而抑制K562细胞增殖,促使其凋亡。 Objective To investigate the effects of tyrosine kinase inhibitor AG-490 on proliferation and apoptosis of chronic myeloid leukemia cell line K562 cells.Methods Chronic myelogenous leukemia cell line K562 cells were in vitro cultured and its proliferation inhibition were detected by MTT assay,K562 cells morphological changes were observed by microscopy,K562 cells apoptosis and cycle were tested by flow cytometry,the expression of bcr/abl mRNA was detected by reverse transcription-polymerase chain reaction(RT-PCR),the expression of bcr/abl and c-myc mRNA were detected by real-time quantitative PCR(RQ-PCR).Results AG-490 could significantly inhibit K562 cell proliferation,and this effect could be more obviously with the extension of time and the increase of concentration;AG-490 could arrest K562 cell cycle at G1 phase,and increase the apoptosis of cells(P0.05).The expression of bcr/abl fusion gene had no changes(P0.05),while the level of c-myc mRNA decreased significantly after treated by AG-490(P0.05).Conclusion AG-490 could be down-regulate the level of expression of c-myc gene via blocking JAK2 signal transduction pathway to inhibit the proliferation of K562 cells and induce the apoptosis of K562 cells by arresting the cell cycle at G1 phase.
出处 《苏州大学学报(医学版)》 CAS 北大核心 2011年第2期234-238,共5页 Suzhou University Journal of Medical Science
关键词 酪氨酸激酶抑制剂 AG-490 K562细胞 细胞增殖 细胞凋亡 tyrosine kinase inhibitor AG-490 K562 cells cell proliferation cell apoptosis
  • 相关文献

参考文献12

  • 1Bustin SA, Benes V, Nolan T. Quantitative real-time RT- PCR--a perspective [ J ]. J Mol Endocrinol, 2005,34 ( 3 ) : 597 - 601.
  • 2Buettner R, Mora LB, Jove R. Activated STAT signaling in human tumors provides novel molecular targets for thera- peutic intervention [ J ]. Clin Cancer Res, 2002,8 (4) : 945 - 954.
  • 3Horiguchi A, Oya M, Marumo K, et al. STAT3, but not ERKs, mediates the IL-6-induced proliferation of renal cancer cells, ACHN and 769P[ J]. Kidney Int, 2002, 61(3) :926 -938.
  • 4Real PJ, Sierra A, De Juan A,et al. Resistance to chemo- therapy via STAT3-dependent overexpression of Bcl-2 in metastatic breast cancer cells [ J ]. Oncogene, 2002, 21 (50) :7611 -7618.
  • 5Ueda T, Bruchovsky N, Sadar MD. Activation of the an- drogen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways [ J ]. J Biol Chem, 2002, 277(9):7076-7085.
  • 6Abe Y, Ono K, Kawamura T, et al. Leptin induces elon- gation of cardiac myocytes and causes eccentric left ventric- ular dilatation with compensation [ J ]. Am J Physiol Heart Circ Physiol, 2007, 292 ( 5 ) :2387 - 2396.
  • 7Meydan N, Grunberger T, Dadi H, et al. Inhibition of acute lymphoblastic leukemia by a Jak-2 inhibitor[ J ]. Nature, 1996,379 (6566) :645 - 648.
  • 8Miyamoto N, Sugita K, Goi K, et al. The JAK2 inhibitor AG490 predominantly abrogates the growth of human B- precursor leukemic cells with 11 q23 trans-location or Phila- delphia chromosome [ J ]. Leukemia, 2001,15 ( 11 ) : 1758 - 1768.
  • 9Samanta AK, Lin H, Sun T, et al. Janus kinase 2:a criti- cal target in chronic myelogenous leukemia [ J ]. Cancer Res,2006,66 ( 13 ) :6468 - 6472.
  • 10Xie S, Lin H, Sun T, et al. Jak2 is involved in c-Myc induction by Bcr-Abl[ J]. Oncogene,2002, 21 (47) :7137 -7146.

二级参考文献9

  • 1Siu IM, Lal A, Blankenship JR, et al. c-myc promoter activation in medulloblastoma[J]. Cancer Research, 2003, 63 (16):4773-4776.
  • 2Friedman HS, Burger PC, Bigner SH, et al. Phenotypic and genotypic analysis of a human medulloblastoma cell line and transplanted xenograft (D341Med) demonstrating amplification of c-myc[J]. Am J Pathol, 1988,130(3):472- 484.
  • 3Fuhrmann G, Rosenberger G, Grusch M, et al. The MYC dualism in growth and death[J]. Mutat Res, 1999,437(3): 205 -208.
  • 4DuHadaway JB, Sakamuro D, Ewert DL, et al. Binl mediates apoptosis by c-myc in transformed primary cells[J]. Cancer Res, 2001,61(7):3151-3156.
  • 5Pajic A, Spitkovsky D, Christoph B, et al. Cell cycle activation by c-myc in a burkitt lymphoma model cell line[J]. Int J Cancer, 2000,87(6):787-791.
  • 6Wickstrom EL. Human promyelocytic leukemia HL-60 cell proliferation and c-myc protein expression are Inhibited by anantisensepenta-decadeoxynucleottde targeted against c- myc mRNA[J]. Proc Natl Acad Sci USA, 1988,85(4): 1028-1033.
  • 7Sumimoto H, Yamagata S, Shimizu A, et al. Gene therapy for human small-cell lung carcinoma by inactivation of Skp-2 with virally mediated RNA interference [J]. Gene Ther, 2005,12(1):95-100.
  • 8Borkhardt A. Blocking oncogenes in malignant cells by RNA interference:new hope for a highly,specific cancer treatment[J]. Cancer Cells, 2002,2(3) : 167-168.
  • 9党双锁,李林瑞,刘效恭,李国威,孙新民,程延安.脂质体介导c-myc基因反义寡核苷酸对人肝癌细胞的生物学影响[J].中华实验外科杂志,2000,17(6):533-534. 被引量:15

共引文献2

同被引文献6

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部